Trinity Biotech plc (TRIB) Misses Q4 EPS by 2c

Trinity Biotech plc (NASDAQ: TRIB) reported Q4 EPS of $0.18, $0.02 worse than the analyst estimate of $0.20. Revenue for the quarter came in at $26 million versus the consensus estimate of $27 million.

For earnings history and earnings-related data on Trinity Biotech plc (TRIB) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• INVO Fertility (IVF) Tops Q2 EPS by 105c
• Benchmark Reiterates Buy Rating on Odysight.AI Inc. (ODYS)